Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Journal of the American Society of Nephrology : JASN|October 11, 2024
Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical TrialAndrew S Bomback, Leal C Herlitz, Priyanka Punit Kedia, et al.
The American Journal of Clinical Nutrition|September 11, 2009
Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA)Andrew S Bomback, Ronit Katz, Ka He, et al.
American Journal of Nephrology|June 23, 2012
Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trialAndrew S Bomback, Pietro A Canetta, Laurence H Beck, et al.
Current Hypertension Reports|July 8, 2018
Future Direction for Using Artificial Intelligence to Predict and Manage HypertensionChayakrit Krittanawong, Andrew S Bomback, Usman Baber, et al.
Pediatric Transplantation|November 22, 2021
Use of ofatumumab and eplerenone in post-transplant recurrence of FSGSNamrata G Jain, Justin K Chen, Ruchi Mahajan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
IgA nephropathy with minimal change diseaseLeal C Herlitz, Andrew S Bomback, Michael B Stokes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Use of bortezomib in heavy-chain deposition disease: a report of 3 casesKinjal Patel, John J Dillon, Nelson Leung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2009
Rituximab therapy for membranous nephropathy: a systematic reviewAndrew S Bomback, Vimal K Derebail, Julie G McGregor, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2014
Rituximab treatment for fibrillary glomerulonephritisJonathan Hogan, Michaela Restivo, Pietro A Canetta, et al.
Frontiers in Immunology|February 9, 2026
Opportunities and challenges in recurrent diffuse podocytopathy post-transplantation: the critical value of the definitionRachel Nuccitelli, Amadea Toutoungis, Elena Martinelli, et al.
Pageof 17